Bipolar disorder is treated with a combination of medication, therapy, and lifestyle strategies tailored to the specific type and phase of the illness. Most people need a mood stabilizer or antipsychotic as their foundation, paired with psychotherapy that targets the unique rhythm disruptions bipolar disorder causes. Treatment looks different depending on whether someone is managing an acute manic or depressive episode versus preventing the next one.
Mood Stabilizers: The Foundation
Lithium remains the most established mood stabilizer for bipolar disorder. It works for both acute mania and long-term prevention of mood episodes. During maintenance treatment, blood levels are typically kept above 0.6 mEq/L to stay effective, while acute manic episodes often require levels in the 0.8 to 1.2 mEq/L range. Lithium requires regular blood draws because the margin between a therapeutic dose and a toxic one is narrow. Levels that stay above 1.5 mEq/L can cause tremor, slurred speech, nausea, and muscle weakness. Above 2.5 mEq/L, severe neurological problems like seizures can develop. Concentrations above 3.5 mEq/L are considered potentially fatal.
What makes lithium tricky is that blood levels don’t always reflect what’s happening in the brain. Some people develop neurological side effects even when their blood work looks normal. This is why monitoring symptoms matters just as much as monitoring labs.
Anti-seizure medications also function as mood stabilizers. Valproate (often prescribed as divalproex) has been used for mania since its FDA approval for that purpose in 1994, and it’s particularly useful for people who don’t respond well to lithium or who experience rapid cycling. Lamotrigine fills a different niche: it’s FDA-approved specifically for preventing relapses of bipolar depression, making it one of the few medications that targets the depressive side of the illness rather than the manic side. It doesn’t do much for acute mania, so it’s not a one-size-fits-all option.
Antipsychotics for Bipolar Depression
The depressive episodes of bipolar disorder are often harder to treat than the manic ones, and they tend to dominate the illness over time. A class of newer antipsychotic medications has become central to managing these episodes. Interestingly, most antipsychotics don’t help depression at all. The ones that do tend to work at lower doses, where they affect the brain differently than they do at higher, mania-treating doses.
Quetiapine and cariprazine are the only two antipsychotics approved for treating both manic and depressive episodes. Quetiapine stands out for people who also struggle with anxiety and insomnia, which is common in bipolar depression. It has proven anti-anxiety effects in controlled trials and meaningfully improves sleep. Cariprazine is considered a strong all-around option because it covers both mood poles and is relatively well tolerated, though its effect on depression is somewhat weaker than the alternatives. Lurasidone is another option for bipolar depression that carries less risk of weight gain and metabolic problems, but it’s more likely to cause akathisia, a restless, agitated feeling that many people find hard to tolerate.
These medications typically start working within two weeks, with full effects visible by four weeks. That timeline matters when you’re in the middle of a depressive episode and weighing whether a medication is helping.
Metabolic Monitoring on Medication
Antipsychotics can cause significant weight gain and metabolic changes, including elevated blood sugar and cholesterol. Current guidelines recommend checking weight and BMI at baseline, then at weeks 4, 8, and 12, and every three months afterward. Fasting blood sugar and cholesterol panels are checked at baseline, again at 12 weeks, and then yearly. People with higher cardiovascular risk may need lipid checks more often.
These aren’t optional extras. Metabolic side effects are one of the most common reasons people stop taking their medication, and untreated, they create serious long-term health risks. If you’re gaining weight rapidly or noticing changes in appetite or thirst, that’s worth raising with your prescriber early rather than waiting for the next scheduled lab draw.
Treating Bipolar I vs. Bipolar II
The distinction between bipolar I and bipolar II changes treatment in important ways, especially around antidepressants. In bipolar I, antidepressants carry a real risk of triggering a manic episode, so they’re almost always paired with a mood stabilizer or antipsychotic as a safety net. In bipolar II, where full-blown mania doesn’t occur (the “highs” are milder hypomanic episodes), antidepressants may sometimes be used alone. This doesn’t mean the risk is zero, but it gives prescribers more flexibility.
Bipolar II tends to be dominated by depression, which means lamotrigine and the antipsychotics approved for bipolar depression often play a larger role in treatment plans. Bipolar I treatment, by contrast, frequently prioritizes lithium or valproate to prevent manic episodes from recurring.
Therapy That Targets Rhythm Disruption
Medication manages the biology, but therapy addresses the behavioral patterns that trigger episodes. Interpersonal and Social Rhythm Therapy (IPSRT) was designed specifically for mood disorders. Its core idea is that people with bipolar disorder have underlying disturbances in their biological clocks, and that stabilizing daily routines can stabilize mood.
In practice, IPSRT helps you build consistent schedules for sleep, meals, exercise, and social activity. It also focuses on improving medication adherence, managing stressful life events, and reducing the kinds of routine disruptions that can tip someone into a mood episode. The therapy teaches skills meant to protect against future episodes, not just manage current symptoms. Cognitive behavioral therapy is also used for bipolar disorder, particularly for identifying distorted thinking patterns during depressive episodes and developing coping strategies.
Why Sleep Is Non-Negotiable
Sleep disruption is both a symptom of bipolar disorder and a trigger for episodes. People with bipolar disorder experience alterations in circadian rhythms that can destabilize normal sleep patterns and provoke mania. The general recommendation is at least seven hours of sleep per night, but consistency matters just as much as duration. Going to bed and waking up at roughly the same time, falling asleep without long delays, and sleeping through the night without frequent disruptions are all part of protective sleep hygiene.
During mania, the relationship with sleep shifts. The decreased need for sleep in mania isn’t insomnia in the traditional sense. Someone in a manic state genuinely feels restored after very little sleep. This can mask the severity of what’s happening and delay recognition of an episode. If you notice that you feel fully energized on three or four hours of sleep and this is a change from your baseline, that’s a significant warning sign.
Recognizing Early Warning Signs
Catching an episode early, during what’s called the prodromal phase, gives you the best chance of preventing a full relapse. The warning signs differ depending on which direction the mood is shifting.
Early signs of mania include elevated or irritable mood lasting more than six hours a day, racing thoughts, talking faster than usual, a noticeable surge in energy, and engaging in reckless behavior. Early signs of depression include sustained low mood for more than six hours a day, loss of interest in things you normally enjoy, difficulty concentrating, social withdrawal, and appetite changes.
Other warning signs that can precede either type of episode include mood swings, sleep disturbances, increased anxiety, and a general decline in your ability to function at work or in relationships. Beyond these common patterns, each person tends to develop their own unique set of warning signs. Keeping a mood journal or working with a therapist to identify your personal patterns makes early intervention much more practical.
Brain Stimulation for Treatment-Resistant Cases
When medications and therapy aren’t enough, brain stimulation therapies become an option. Electroconvulsive therapy (ECT) is the most powerful tool available for severe bipolar depression, with remission rates as high as 95% in some studies. It acts faster than other interventions and is the preferred choice when psychotic features are present, meaning the person is experiencing delusions or hallucinations alongside depression.
Transcranial magnetic stimulation (TMS) is a less intensive alternative that doesn’t require anesthesia. It’s effective for bipolar depression, though less dramatically than ECT. One interesting finding is that TMS works better when patients arrive in a positive mental state, so doing something enjoyable in the hour before treatment can actually improve the response. TMS is typically used when several medications have failed but the situation isn’t severe enough to warrant ECT.